CIENCIASMEDICASNEWS: Gold Nanoparticles Use in Prostate Cancer

sábado, 9 de mayo de 2020

Gold Nanoparticles Use in Prostate Cancer

	Prostate Cancer
	The latest prostate cancer news from News Medical

Gold Nanoparticles Use in Prostate Cancer

Prostate cancer is one of the top four most common cancers globally. The increased use of testing has led to a greater number of cases being detected and requiring treatment. New treatment shows promising outcomes for men diagnosed with low or immediate-risk prostate cancer.

			Analyzing Cancer-Stromal Cell Fusion Using Fluorescence This article looks at cancer-stromal cell fusion and how this can be analyzed using fluorescence. In many cancers, not all areas of the tumor are the same; this is said to be “heterogeneous”. This is a process that occurs progressively. This can arise through genomic alterations (mutations and chromosomal alterations) acquired by tumor cells.

			'Smart toilet' looks for signs of disease A Stanford study published in the journal Nature Biomedical Engineering in April 2020 reports the development of a new kind of toilet that can pick up signs of an extensive range of diseases, from molecules in stool and urine.

	Study finds abnormal alternative RNA splicing patterns in aggressive prostate cancer Aggressive forms of prostate cancer don't act the way they should, hanging on to genetic materials called introns that should be thrown away, a new six-year study led by Dean Tang, Ph.D., and Song Liu, Ph.D., of Roswell Park Comprehensive Cancer Center has revealed.

	Higher levels of specific gene can indicate better prognosis in prostate cancer The most common form of cancer in older men is prostate cancer. In many cases the tumor grows slowly and can be treated effectively, but it is sometimes more aggressive and becomes terminal.

	Mathematical model can predict patient outcomes to adaptive prostate cancer therapy Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.